Toggle Main Menu Toggle Search

Open Access padlockePrints

Impact of Lymphadenectomy on Survival After Unimodality Transthoracic Esophagectomy for Adenocarcinoma of Esophagus

Lookup NU author(s): Professor Alexander PhillipsORCiD, Maziar Navidi, Anantha Madhavan, Arul Immanuel, Professor Michael Griffin


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© 2019, Society of Surgical Oncology.Background: Debate remains regarding the extent of lymphadenectomy required with esophagectomy. In patients who receive neoadjuvant treatment, this may address lymph node metastases. However, patients with early disease and those with comorbidities may not receive neoadjuvant treatment. The aim of this study is to determine the impact of lymph node yield and location on prognosis in patients undergoing esophagectomy without neoadjuvant treatment. Patients and Methods: Data from consecutive patients with potentially curable adenocarcinoma of the esophagus or gastroesophageal junction were reviewed. Patients were treated with transthoracic esophagectomy and two-field lymphadenectomy. Outcomes according to lymph node yield were determined. The prognosis of carrying out less radical lymphadenectomy was calculated according to three groups: exclusion of proximal thoracic nodes (group 1), minimal abdominal lymphadenectomy (group 2), and minimal abdominal and thoracic lymphadenectomy (group 3). Results: 357 patients were included. Median survival was 78 months [confidence interval (CI) 53–103 months]. Absolute lymph node retrieval was not related to survival (p = 0.920). An estimated additional 4 (2–6) cancer-related deaths was projected if group 1 nodes were omitted, 15 (11–19) additional deaths if group 2 nodes were omitted, and 4 (2–6) deaths if group 3 nodes were omitted. Minimal lymphadenectomy (groups 1, 2, and 3) was projected to lead to 19 (15–23) additional cancer-related deaths. Conclusions: Extensive lymphadenectomy allows accurate staging. In patients who do not receive neoadjuvant treatment, it may confer a survival benefit. The number of lymph nodes retrieved may not be a good surrogate for extent of lymphadenectomy, and correlation with location is required.

Publication metadata

Author(s): Phillips AW, Hardy K, Navidi M, Kamarajah SK, Madhavan A, Immanuel A, Griffin SM

Publication type: Article

Publication status: Published

Journal: Annals of Surgical Oncology

Year: 2019

Issue: ePub ahead of Print

Online publication date: 11/10/2019

Acceptance date: 02/04/2019

ISSN (print): 1068-9265

ISSN (electronic): 1534-4681

Publisher: Springer New York LLC


DOI: 10.1245/s10434-019-07905-8

PubMed id: 31605326


Altmetrics provided by Altmetric